CJ Bioscience
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
311690 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 중구 세종대로 14 그랜드센트럴타워 B동 7층, 중구
- Website:
- https://www.cjbioscience.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CJ Bioscience, Inc. is a biopharmaceutical company focused on developing next-generation, microbiome-based therapeutics. Leveraging its proprietary AI-powered drug discovery platform, Ez-Mx®, the company analyzes the relationship between human microbiomes and disease to address unmet medical needs. Its therapeutic programs are concentrated on oncology and inflammatory bowel disease (IBD), with a pipeline of live biotherapeutic products. CJ Bioscience aims to create innovative treatments, such as orally administered drugs, designed to offer improved safety and convenience compared to existing therapies.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CJ Bioscience and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all CJ Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for CJ Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
